This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A select group of eight radionuclides holds hope for an emerging cancer treatment in nuclearmedicine called targeted alpha therapy (TAT). Ultimately, most hospitals conducting trials receive doses of these eight radionuclides from upstream radiopharmaceutical production facilities, with U.S.
With therapeutic radiopharmaceuticals coming to market quickly and available to smaller institutions around the U.S., those interested in expanding care using emerging radioligand therapies (RLTs) may be deciding on how to start or where to expand. We think all of those things are really necessary for optimal patientcare."
In any case, for Pickhardt, research is key to providing high-quality patientcare. "I I love how research improves my clinical acumen and 'moves the needle' for patientcare," he said. Most Effective Radiology Educator Francis Deng, MD, Johns Hopkins Medicine Francis Deng, MD. Dmitry Beyder.
Obviously, I accepted his offer, and I taught a couple of [radiologic sciences] labs as an adjunct, and one of the first labs I was asked to teach was a patientcare lab," she said. "It For example, in patientcare courses there is a natural crossover. But Hennessy encouraged her. It was an immediate sense of joy."
Anderson , PhD, a trailblazer in nuclearmedicine, has been named the 2024 recipient of the Georg Charles de Hevesy Nuclear Pioneer Award. The award was announced by the Society of NuclearMedicine and Molecular Imaging (SNMMI) during its 2024 Annual Meeting, June 8-11 in Toronto.
Medical School: They then complete four years of medical school, mastering the fundamentals of anatomy, pathology, pharmacology, and patientcare. NuclearMedicine and Theranostics : Nuclearmedicine radiologists specialize in advanced imaging techniques, such as PET/CT scans, to detect and treat conditions at the molecular level.
30, 2025 Earlier this month, the Society of NuclearMedicine and Molecular Imaging (SNMMI) and the Alzheimers Association released updated appropriate use criteria (AUC) for amyloid and tau PET imaging in patients with mild cognitive impairment, Alzheimers disease and other dementias. tim.hodson Thu, 01/30/2025 - 10:20 Jan.30,
Radiopharmaceuticals in diagnostics provide critical insights into disease processes, improving accuracy, patientcare, and treatment outcomes significantly. The post The Transformative Power of Radiopharmaceuticals in Diagnostics appeared first on Open MedScience.
Mahmood was presented the award by the Society of NuclearMedicine and Molecular Imaging (SNMMI) at its 2023 Annual Meeting. Award recipients will have initiated, developed, and successfully implemented unique and significant transformative value within the field of nuclearmedicine and molecular imaging.
As vice president-elect, my primary goal will be to strengthen SNMMI as a valuable resource for all members, from advancing the field's underlying basic science to providing excellent evidence-based patientcare,” stated Jacene. “I An active SNMMI member, Jacene has been involved in many aspects of the organization.
milla1cf Fri, 04/05/2024 - 11:31 April 5, 2024 — RLS Radiopharmacies , America’s only Joint Commission-accredited radiopharmacy network, today announced it has expanded its radiopharmaceutical contract development and manufacturing (rCDMO) capabilities by entering into a strategic agreement with global isotope technology leader Eckert & Ziegler.
milla1cf Fri, 06/23/2023 - 22:04 June 23, 2023 — Cardinal Health Nuclear & Precision Health Solutions (NPHS) (Booth #2041) will feature information on radiotherapies and theranostics readiness at the Society of NuclearMedicine & Molecular Imaging (SNMMI) 2023 Annual Meeting.
By the end of June 2023, commercial production across the country will be underway at the 31 PETNET radiopharmacies Blue Earth Diagnostics included in its New Drug Application for POSLUMA, marking a record number of sites authorized for the manufacturing of a radiopharmaceutical upon its initial FDA approval.
For the practice of precision care in molecular imaging and nuclearmedicine, this begins with the production of radioisotopes for use in diagnostic tracers, which are administered to patients, attach to specific biomarkers, and release radioactive emissions to provide clinicians detailed molecular information unique to each patient.
8, 2025 The Society of NuclearMedicine and Molecular Imaging (SNMMI) and the Alzheimers Association have released updated appropriate use criteria (AUC) for amyloid and tau PET imaging in patients with mild cognitive impairment, Alzheimers disease and other dementias. tim.hodson Tue, 01/14/2025 - 16:48 Jan.8,
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content